FDA's Generic-Drug Plan Will Live Or Die On Sameness Rule
Though the U.S. Food and Drug Administration plans to allow generic-drug makers to change their warning labels, the agency's authority to do so will depend on finding wiggle room in the...To view the full article, register now.
Already a subscriber? Click here to view full article